ScienceDex / Researcher record
Matthew L Freedman
- Dana-Farber Cancer Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,118,391 | 4 | #4,834 |
| 2025 | $2,837,105 | 4 | #3,749 |
| 2026 | $3,649,312 | 4 | #4,782 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20254 records
- FY2026 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6362098Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
FY2026 award records by amount
NIH award records listing Matthew L Freedman as a PI. Multi-PI records show the full award amount for context.
- $2.5Maward amount
- 5R01CA259058-04R01Co-investigatorCommon biology underlying pleiotropic breast, prostate and ovarian cancer risk lociUT Health Science Center Houston · Internal Medicine (NIH department code)$590Kaward amount
- 5R01CA300092-02R01Contact PIMapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making$406.5Kaward amount
- 3R01CA300092-02S1R01Contact PIMapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making$201.5Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Matthew L Freedman as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4834
- 2024Entered Top 25% NationallyRanked #4834
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Matthew L Freedman.